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Abstract
Objective—To document the lived experiences of people with both poor mental health and 
suboptimal adherence to antiretroviral therapy in high HIV prevalence settings.
Methods—In-depth qualitative interviews were conducted with 47 (female =31) HIV-positive 
adults who scored above the cut-point on a locally-validated scale for common mental disorders. 
Purposive sampling was used to recruit participants with evidence of poor adherence. Six 
additional key informant interviews (female = 6) were conducted with healthcare workers. Data 
were collected and analysed inductively by an interdisciplinary coding team.
Results—The major challenges faced by participants were stressors (poverty, stigma, marital 
problems) and symptoms of common mental disorders (“thinking too much”, changes to appetite 
and sleep, “burdened heart”, and low energy levels). Thinking too much, which appears closely 
related to rumination, was the symptom with the greatest negative impact on adherence to 
antiretroviral therapy among HIV-positive adults with common mental disorders. In turn, thinking 
too much was commonly triggered by the stressors faced by people living with HIV/AIDS, 
especially poverty. Finally, participants desired private counselling, access to income generating 
activities, and family engagement in mental health care.
Conclusions—Better understanding of the local expression of mental disorders and of 
underlying stressors can inform the development of culturally sensitive interventions to reduce 
common mental disorders and poor adherence to antiretroviral therapy.
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Introduction
In low and middle countries (LMICs), common mental disorders (CMDs), mainly mood and 
anxiety disorders, have an estimated lifetime prevalence of 22% [1] and often remain 
undiagnosed and untreated [2]. CMDs, especially depression, are often comorbid with other 
chronic illnesses, such as diabetes [3], epilepsy [4], cardiovascular disease [5], and HIV/
AIDS [6-8]. For people with these chronic diseases, CMDs can be a major barrier to 
adherence to daily medication routines. In particular, the effects of depression on 
antiretroviral therapy (ART) adherence for people living with HIV/AIDS (PLWHA) are well 
established in several contexts [9-18]. Depression may affect adherence by impairing 
concentration, memory, problem solving, and motivation [19-22]. Moreover, poor mental 
health predicts faster HIV progression when controlling for adherence [23-26]. Developing 
interventions to tackle depression and other CMDs in PLWHA is thus critical in addressing 
the global HIV/AIDS pandemic [12,27,28].
Core experiences of CMDs appear to differ cross-culturally [29-32]. In Zimbabwe, a core 
experience of CMDs is ‘kufungisisa,’ which translates directly from Shona as “thinking too 
much” [33-35] and is experienced by up to 80% of Zimbabweans with CMDs [36]. Research 
from several other countries including Uganda [37], Tanzania [38], Nepal [39], Nicaragua 
[40], Cambodia [41], and Haiti [42] have demonstrated that thinking too much is a common 
core component of common mental disorders in many different contexts and has now been 
included in the new Diagnostic and statistical manual of mental disorders (DSM-5) [43]. 
Kufungisisa appears closely related to symptoms of worry and rumination associated with 
depression and anxiety disorders [44]. Research in Zimbabwe has also provided preliminary 
evidence that brief psychological therapy based on problem solving therapy (PST) is an 
appropriate and effective intervention for CMDs and symptoms such as kufungisisa [45]. 
This baseline understanding of CMDs in Zimbabwe provides a useful starting point in the 
development of a culturally appropriate psychosocial intervention for PLWHA. Additional 
research on quality of life for patients on ART has become a major public health focus [46], 
and has improved our understanding of the factors that play into wellbeing for PLWHA such 
as “live-ability” of the patient's environment. While several studies that use this framework 
have been conducted in countries such as Uganda [47,48], no such research have been 
conducted in Zimbabwe and there is still limited understanding of the determinants or nature 
of CMDs specifically among PLWHA in Zimbabwe.
This qualitative study sought to inform the development of a culturally-appropriate 
intervention in Zimbabwe for PLWHA with comorbid CMDs and poor adherence to ART. 
Research from the United States (US) has shown that interventions based on motivational 
interviewing, problem-solving around barriers to adherence, and cognitive behavioral 
therapy (CBT) can improve mental health and adherence to ART in depressed PLWHA 
[49-51]. A key step in designing a similar intervention is to understand the lived experiences 
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of patients within their local context. For an intervention focused on both CMDs and 
adherence, an appreciation of the major factors contributing to both poor mental health and 
poor adherence is crucial. In addition, it is useful to understand the facilitators for an 
intervention in this population in order to meet context-specific needs and preferences. Since 
very little was known about the lived experiences of HIV- positive adults with co-morbid 
CMDs and poor adherence in Zimbabwe, qualitative methods were appropriate for exploring 
in-depth features of their lives to help develop a culturally-appropriate intervention [52].
Methods
Setting
The study was conducted from August 2013 to July 2014 at the HIV clinic of Parirenyatwa 
Hospital in Harare, Zimbabwe: one of the largest HIV treatment facilities in the country with 
a total enrolment of over 8000 patients. Adherence counseling is provided for all patients, 
and those with mental health problems are referred to psychiatric services. Prior to our 
study, adherence counseling at the clinic included giving a broad range of information about 
HIV, ART, and sexual behavior rather than focusing on helping the patient with adherence. 
Sometimes, this included reprimanding patients for non-adherence and describing the grave, 
potentially fatal consequences of poor adherence
Study Design and Sample
We conducted 47 in-depth, qualitative interviews. Inclusion criteria were adult patients (18 
years and older) who scored greater than 5 on the Shona version of the Self Report 
Questionnaire (SRQ-8) [53] - a culturally-adapted and validated psychiatric screening tool 
for CMDs in Zimbabwe. We used purposive sampling to capture participants thought likely 
to benefit from additional support to promote adherence. Indication of potential poor 
adherence was via any one of: 1) referral of patients with biological surrogates suggesting 
poor adherence (a CD4 count below 350 that had fallen since the last clinic visit or a viral 
load that had increased since the last clinic visit); 2) self reported missed doses in the last 6 
months; or 3) self reported missed clinic visits in the last 6 months. Following interviews, all 
clients with significant mental health needs were linked to psychiatric services in an adjacent 
hospital. Additionally, we conducted 6 key informant interviews with healthcare workers 
(HCWs) involved in the HIV management of these patients. Among HCWs, several key 
informants such as counselors, nurse practitioners, and a clinical psychologist were 
identified as particularly knowledgeable about the psychosocial issues affecting clinic 
attendees. Characteristics of the interview sample are presented in Table 1.
Data Collection
Interviews lasted between 45 and 65 minutes. The interviewers were local Zimbabweans 
with training in qualitative research and fluency in the local vernacular (Shona). The initial 
interview guide was written in English, translated into Shona, and back translated to ensure 
clarity. The guide was piloted in a non-clinical setting and adjusted in order to ensure that 
conversations were non-leading and flowed well. Interviewers were trained to use the 
interview guide (Table 2) in both languages and gave participants the option of participating 
in English, Shona, or a combination of the two. The interviewers used the guide (and a 
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modified version for HCWs) to speak to participants about their experiences on ART, their 
challenges in life, and what motivated them to stay alive.
Researchers ensured a constant comparative approach to data collection by discussing 
emerging themes throughout the data collection process [54]. In weekly meetings, the 
interviewers gave feedback to the senior qualitative researcher (KK) about emerging themes 
and the suitability of the interview guide. These discussions formed an important 
preliminary analysis, which allowed the interview guide to evolve in parallel with data 
collection and assisted in determining when theoretical saturation had been reached [55], 
after which no additional interviews were conducted. All interviews were audio-recorded 
and later transcribed verbatim. Two participants elected not to be audio recorded, so 
interviewers took hand-written notes instead.
Data Analysis
Two Zimbabweans with Master's degrees and training in qualitative health research (KK, 
DM) each independently reviewed three randomly-selected transcripts and met three times 
in order to develop a mutually-agreeable, initial coding framework. The same researchers 
then performed line-by-line open coding of each individual transcript using the initial 
framework and met frequently to reconcile codes. NVivo QSR 10 was used to assist data 
analysis and retrieval.
The research team then met several more times, both face-to-face and via video 
conferencing. The team developed hypotheses inductively, performing axial coding (sorting 
codes into categories and determining how these categories are interconnected) and then 
selective coding (integrating concepts to form a descriptive model) [54]. Selected quotations 
are used in the results section to illustrate the major themes that emerged.
Ethical Considerations
We obtained informed written consent from all participants. Ethical approval for the study 
was obtained from: Research Council of Zimbabwe, Medical Research Council of 
Zimbabwe, the Joint Research and Ethics Committee of the University of Zimbabwe, and 
the Research Ethics Office of King's College, London.
Results
This study provides insight into the experiences of PLWHA with comorbid depression and 
poor adherence to ART. Participants described the major challenges they experienced in 
their daily lives, which were stress-ors (poverty, stigma, and marital problems) and 
symptoms of CMDs (thinking too much kufungisisa, burdened heart moyo unorwadza, 
changes to appetite and sleep, and low energy levels). These challenges further impacted on 
adherence and access to ART in variety of ways. Participants also described ideas for the 
intervention. A description of these results is presented below and illustrating quotations 
from participants are provided in Table 3 and Table 4. Figure 1 is a diagrammatic 
representation of our findings.
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Challenges
Poverty
Poverty was the most significant challenge faced by participants in this is study, most of 
whom attended the clinic because ART is dispensed free of charge. HCWs noted that the 
plight of many patients at the clinic was related to the overarching economic climate and 
high unemployment rate in Zimbabwe:
A lot of patients who come to us are people who are not working, because they get 
their medication for free, they get medical facilities free ... So obviously they have 
financial problems and because the economy is not doing very well, they do not 
have any support from the government ... the economy is so bad, so these things 
affect them. And you notice them when they come, they're talking about these 
problems: ‘No money for rent. No money for school fees.’ A lot of their children 
have dropped out of school because of a lack of finances. So that has affected a lot 
of our clients (Clinical psychologist).
Not having enough money was a barrier to meeting essential needs such as food and also 
reduced the mobility of patients, who could not afford rising transport costs. Participants 
cited poverty as a cause of their symptoms:
Now my child has been sent back home from school. What am I supposed to do 
with the child? I started crying. I don't have anything to do. I don't go to work. 
Sometimes I wash clothes and sweep for people for money. But right now, I don't 
have anything to do, not even selling sweets. My child is not going to school (ID# 
28, Female, 44yrs).
I was thinking about money to pay rent so I had a lot on my mind ... Sometimes I 
feel depressed when my money is not enough (ID#23, Female, 32yrs).
Stigma
Participants faced stigma both within the wider community and in their families:
Where I go for laundry they don't know that I am [HIV] positive. Today, I told 
them that my mother is not feeling well and I want to go with her for a check up. I 
cannot tell them that [I am HIV-positive]... stigma is still there (ID#28, Female, 
44yrs).
If the family undergoes counselling they get to understand the need that there is no 
need to discriminate or isolate their relative living with HIV in terms of food and 
beverages as well as ablution facilities. This helps in that if this person is accepted, 
he will not be stressed as he has a support system (Nurse 3).
Self-disclosure was a major issue and most participants experienced internalized stigma and 
felt that they could not tell work colleagues, friends, or family about their HIV statuses. 
Participants were also prone to external stigma, and were often ostracized from communities 
or families: “If our friends and relatives understand that being HIV-positive does not mean 
you are promiscuous, life would be much better” (ID#16, Female, 32yrs). The constant 
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battle with stigma and difficulty in maintaining privacy was often a source of stress and 
worry for participants.
Marital problems
Most married women in this study, including those married to serconcordant men, faced 
marital problems. They frequently made comments such as, “I sometimes get depressed 
because my husband wants a baby but my cells have not yet reached the required number for 
me to get pregnant” (ID#23, Female, 32yrs). These problems were entangled in greater 
issues of HIV status disclosure, economic hardship, the maternal burden of care, and 
patriarchy. Women described husbands to be stingy with sharing their incomes, 
compounding the stress of financial constraints for many women:
My husband does not give me a single cent. He earns a lot of money but he does 
not give us a cent ... The other day, he said to me, ‘let's go to a wedding.’ I said, ‘I 
don't have clothes to wear,’ so he said, ‘that's okay,’ and just left me alone and 
went by himself. I think what my husband is doing actually depresses me (ID#30, 
Female, 44yrs).
The burden of maternal care for women was also significant, as several felt abandoned and 
had to perform all parental duties alone:
I was once married before and I have a child. Then I got married a second time, so 
my husband doesn't like my child that much. The living conditions for my child are 
harsh. That's what stresses me a lot (ID#26, Female, 30yrs).
Many women said that their husbands abused them verbally and physically, or asserted their 
dominance in the household to a degree that severely limited the perceived freedom of most 
women: I was being mentally abused and physically abused, so it was tough for me (ID#38, 
Female, 28yrs).
Symptoms of CMDs
For many participants, the symptoms they experienced relating to depression and anxiety 
posed a significant challenge because many of these symptoms hindered their daily 
activities. Some participants described having ‘burdened hearts’ (moyo unorwadza) when 
explaining their worries, giving the impression that they were weighed down by this anxiety 
and worry: My heart feels burdened and I think about how long I will survive like this. 
(ID#25, Female, 39yrs).Respondents also experienced low energy, lack of appetite, and 
social withdrawal:
After crying, I fell asleep. I didn't even think of cooking for my child. I spent the 
whole day like that.” (ID#28, Female, 44yrs)
What I've noticed, when I'm very much under stress, although my stress sometimes 
happens maybe before or after, you don't have appetite. (ID#33, Female, 49yrs)
However, the most prominent and challenging symptom mentioned by every participant was 
kufungisisa, or ‘thinking too much’: Being depressed is thinking too much. It's when you are 
burdened (ID#32, Male, 66yrs). Participants described kufungisisa as negative or stressful 
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thoughts that filled their minds all the time. Participants would ‘think too much’ about the 
other challenges in their lives such as financial constraints, stigma, and marital problems:
I was thinking about money to pay rent so I had a lot on my mind... If your mind is 
always occupied you will not become strong because your brains will be occupied 
always (ID#23, Female, 32yrs).
You start to ask yourself questions which were answered long back. You revisit 
some of these questions. Till when am I going to be taking this medication? When 
is the cure going to be discovered? When it's discovered will I be still alive? 
(ID#10, Female, 40yrs).
They would also think too much about the causes of past failures and present difficulties (“I 
ask myself if this is happening in other people's marriages”) and about potential future 
problems (“Who will look after the child?”). These negative thoughts were very absorbing 
and often occupied patients’ minds to the degree that it hindered accomplishing tasks within 
their daily routine, including ART adherence.
Impact of challenges on adherence and access to ART
Below we describe how the challenges faced by participants were not only stressors that led 
to poor mental health but also difficulties that impacted ART access and adherence (See 
Figure 1).
Poverty
Respondents described poverty as a barrier to adherence and access to ART in several ways. 
The most common challenge was that without enough money, participants could not pay for 
transport costs from rural locations to the clinic – thus posing a barrier to access of ART:
A lot of people are now going to the rural areas because they can't afford to pay 
rent in the urban areas, which will affect pill taking as well, because when they go 
to the rural area they don't have money to come back and get their medication 
(Clinical Psychologist).
Many participants said they could not afford to feed themselves or their families:
Money is a very big problem. Sometimes I have to sell a chicken, and they're 
almost finished. I have to sell two chickens for me to come here [the HIV clinic], 7 
dollars each, to and fro (ID#31, Male, 37yrs).
I usually come here around 7:30 or 8:00, depending on whether I get transport from 
Mtoko... When I get into town, I walk from Fourth street to Parirenyatwa Hospital 
carrying my child on my back so that I can save money to buy her food (ID#34, 
Female, 33yrs).
Stigma
Stigma faced by participants made it difficult both to take ART and to access it. Participants 
were afraid that members in their communities (neighbours, friends, relatives) would find 
out where they had been when they came to the clinic. This deterred them from attending the 
Kidia et al. Page 7
Trop Med Int Health. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
clinic, and reduced access to ART. Participants avoided taking their medications in public 
settings and even in their own homes in the presence of close family members. This 
particularly became an issue at events where many family members or friends were 
gathered, such as at funerals:
Usually when you travel and also when you attend some functions, such as 
funerals. If you don't find time to get away and have your pills, as you know, 
people are still looking down on you. Stigmatizing you (ID#18, Female, 65yrs).
Marital problems
The challenges faced by women in their marriages also led to difficulties adhering to or 
accessing ART. For example, women married to seroconcordant men often had to share 
their ART with their husbands, who were too embarrassed to attend clinics on their own:
In married couples the female might be the one who has been tested and is 
supposed to be put on medication. Then the husband is not tested and he'll just say 
your status is the same as mine. So the wife will be having the problem that ... the 
husband will be taking the medication as well. So the wife might not feel 
comfortable to come back and say my medication is no longer enough (Nurse 1).
Other women in abusive relationships had to flee their homes, forgetting to take their ART 
with them:
Sometimes I would quarrel with my husband and he would threaten to shoot me. I 
could run to the police station but at that time I could have left my tablets at home, 
you see (ID#38, Female, 28yrs).
Symptoms of CMDs
Symptoms of CMDs, especially kufungisisa, reduced adherence to ART. Participants 
perceived their minds to be occupied by thoughts about the challenges they were 
experiencing in life. These negative thoughts were very consuming and made it difficult for 
participants to concentrate on their daily tasks. Respondents said that kufungisisa made them 
forgetful and that this was a common cause for skipping doses of ART:
It's the thinking too much that makes me forget to take my medication. If I am not 
thinking too much about anything, I remember to take my medication on time. 
When nothing is in my brain, I remember and take them on time (ID#25, Female, 
39yrs).
For some participants, these negative thoughts were so absorbing that they did not even 
notice the regular reminders (such as alarms) that they had in place to help with taking ART 
on time:
When I am thinking too much then I forget, even if the phone [alarm] rings, if my 
thoughts are not collected, I fail to realize that it is ringing for me to take my 
medication (ID#5. Female, 31yrs).
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Intervention Ideas
Family engagement and disclosure
Nearly all respondents said that relationships with family members, especially children, 
were a source of hope and reason to stay alive. Participants wanted to support their children 
financially and emotionally and live to see them grow up. Many participants cited a future 
celebratory occasion such as child's graduation or coming of age as moments to look 
forward to and be present for:
My children motivate me to live longer because when I look at their age, it inspires 
me. I always wish that God could increase the number of years I live, so that I can 
see my children grow up and take care of themselves (ID#2, Female, 37yrs).
Participants also depended on family as a source of support for dealing with the realities of 
being HIV-positive and the routine of ART. For example, respondents said that their 
children often reminded them to take their ART on time:
I usually forget to take my medication. Like on Monday I had forgotten, but my 
child reminded me when I was going to bed. She said, ‘Mum, you haven't taken 
your pills.’ ... What happened is I had a lot on my mind and I was thinking too 
much (kufungisisa)... (ID#25, Female, 39yrs).
HCWs were in favour of engaging family members to help with adherence and with mental 
health. They confirmed that self-disclosure to family members was an important step for 
attaining good adherence. The family is important because they support a person living with 
HIV. That is why we encourage family members to be informed. They are also supposed to 
undergo counselling to get assistance... It encourages him to take medication, peace of mind 
knowing that the people at home love him as he is. It will be easier. The family plays an 
important role. So informing the family and other close friends might benefit him especially 
if they empowered with information on HIV they will be able to help him (Nurse 3).
Income generation and transport
Since poverty was the most significant challenge for most participants, many felt that they 
needed direct financial assistance and/or support seeking employment. Some participants 
had heard of income generation projects at other clinics and wanted to know more about 
accessing this type of assistance:
I also wanted to say something concerning these projects which are being talked 
about especially for [HIV]-positive people. I am being taught, but I don't have the 
capital. I think there should be a small fund from the government or NGOs to assist 
(ID#45, Female, 42yrs).
Participants needed financial assistance particularly for transport costs, and many stated that 
they would attend clinic more regularly if they could meet these costs. HCWs suggested that 
improving transportation for patients was a key area for improvement to assist patients: You 
might [provide] money for transport so we don't have a situation that someone will say they 
cannot come because they have no money for transport. I think if this happens it would help 
a lot (HCW 4).
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Private settings
Privacy was a major priority for participants, who wanted to be able to discuss their personal 
affairs in a setting that afforded personalized psychosocial care from HCWs that they could 
trust. Respondents bemoaned the current lack of confidentiality at the clinic and said that 
they often received counselling in clinical compartments separated only by curtains, 
allowing other patients and HCWs to overhear personal conversations.
Somewhere private, definitely private. I'm the kind of person who doesn't want to 
divulge my personal information to everyone, so a private setting would do. These 
curtains give you a sense of privacy, but they are not private (ID#33, Female, 
49yrs).
When asked for the ideal environment in which to deliver a psychological intervention, most 
respondents stressed that one-on-one sessions were preferable to group therapy, especially 
during initial stages immediately following status disclosure: One to one would be more 
effective, because I can actually ask you where did I get it, and you can actually help me in 
the problems, in my personal problems (ID#36, Male, 49yrs).
Discussion
This study explored the lived experiences of adults on ART with co-morbid CMDs and poor 
adherence in Zimbabwe. It highlighted major challenges, the impact of these challenges on 
adherence and access to ART, and proposed interventions for this population. We confirm 
findings from previous research that challenges such as poverty and stigma are key barriers 
to ART adherence in LMICs [56-59], including Zimbabwe [60] (Effect 1 in Figure 1). Our 
study finds that these barriers have an additional negative effect on ART adherence: they 
contribute to poor mental health, which in turn causes poor adherence (Effect 2 in Figure 1) 
[10,17,61]. For example, poverty makes it difficult to access ART for patients attending an 
urban hospital through inability to meet transport costs, however, it also acts as a stressor 
that feeds into CMDs, leading to poor adherence.
This study documents the importance of ‘thinking too much’ or ‘kufungisisa’ in linking low 
mood and poor adherence to ART. Kufungisisa was commonly triggered by the severe 
stressors faced by PLWHA, especially poverty. Many of the experiences of kufungisisa 
appear to align with rumination, in that they involved repetitive negative thinking about past, 
present, and future events [62].
Our findings are consistent with research from South Africa on HIV-positive women with 
depression, which showed that poverty, stigma, and marital problems were major challenges 
for this population [63]. However, our study was unique in that it included PLWHA with 
both CMDs and suboptimal adherence to ART. While previous research in Zimbabwe has 
suggested that kufungisisa may be a significant component of poor mental health for 
PLWHA in Zimbabwe [45], our study confirms this and suggests that it is the symptom with 
the greatest negative impact on adherence to ART in Zimbabwe. Since this is the first study 
to explore how kufungisisa may affect ART compliance, we extend current literature on 
barriers to ART adherence in Zimbabwe [60,64], and in other countries where ‘thinking too 
much’ is a core experience of CMDs.
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Although dealing with the symptoms of CMDs was a major challenge itself for participants, 
many linked their symptoms to specific life stressors such as poverty, stigma, and marital 
problems. The symptoms of CMDs exacerbated the negative experiences of stressors, 
creating a cyclical relationship between those stressors and CMDs [65] (See Figure 1). 
Notably, kufungisisa was instrumental in establishing and sustaining the negative depressive 
cycle, because patients would ‘think too much’ about the difficulties that they were facing in 
their daily lives.
The most common challenge that participants ‘thought too much’ about was financial 
hardship. Poverty was pervasive among participants in the study, underscoring the close 
relationship between economic hardship and poor mental health. Although it is well 
established that in low- and middle- income countries mental illness and poverty are linked 
in a cyclical, mutually-reinforcing manner [66], the effect of such a relationship may be 
further pronounced in Zimbabwe, a country that not only has a high HIV prevalence but also 
has endured a serious economic recession over the last decade.
Our findings have several implications for the integration of mental health into HIV services 
in Zimbabwe – a key goal of the country's mental health policy [67] and an area of active 
engagement by international organizations working in the country such as USAID [68]. 
Given the twofold impact of stressors such as poverty on both CMDs and adherence to 
ART, this study emphasizes that mental health interventions for CMDs alone may not be 
sufficient to completely address the burden of CMDs in this population, especially when a 
concurrent goal is to improve adherence and access to ART. Tackling the stressors that feed 
into CMDs – poverty, stigma, marital problems – serves a dual purpose and is key to 
breaking the negative depressive cycle and to addressing major barriers to ART adherence.
Within our setting, these results can inform an intervention in a number of ways. First, our 
findings underscore the need for educating HCWs about how poverty, stigma, and marital 
problems impact on their patients’ ability to adhere to ART. Second, information about the 
sources of hope for this population, such as family relationships, is useful for motivating 
patients to engage with care and break the negative depressive cycle. This underscores the 
importance of disclosure and involvement of family members in the delivery of mental 
health care and promotion of adherence, as has been established in previous research 
[69-73]. Third, the emphasis on privacy in participants’ responses highlights the need for 
one-on-one interactions with HCWs, over group counseling interventions.
A significant limitation of our findings was social desirability bias among participants. We 
noted that participants were reticent to open up about episodes of poor ART adherence 
during the interview, likely due to fears of being reprimanded by clinic staff members. 
Despite this, we took several measures to ensure that participants felt comfortable to speak 
freely, including making audio-recording optional, phrasing questions in an open-ended 
manner, and using private rooms to conduct our interviews.
Our findings are limited in their generalizability to other contexts. The sample included only 
PLWHA with CMDs at one major HIV clinic, and did not incorporate the perspectives of 
those without CMDs or good adherents with CMDs. However, we prioritized an 
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information-rich, purposive sample of poor-adhering clinic attendees with CMDs because 
this was the population for whom we were designing an intervention. Comprehensive 
perspectives on CMDs among PLWHA in the wider Zimbabwean community are still 
lacking, and this is an important area for future research.
Conclusions
Since this study was conducted, we have used our understandings of the challenges of 
PLWHA in Zimbabwe to adapt an adherence intervention that uses motivational 
interviewing techniques [19] and culturally-appropriate metaphors for HIV and ART. We 
have incorporated PST techniques focused on problem-solving around stigma and financial 
constraints. For example, by helping clients to change their appointment times to suit their 
schedules, to identify ways to take medication in private, and to generate solutions that 
enable them to seek employment, earn small amounts of capital, save, and invest. 
Ultimately, our findings demonstrate that an appreciation of stressors such as poverty on the 
mental health of PLWHA and a better understanding of the local expression of mental 
disorders are both crucial for developing culturally sensitive psychological interventions for 
adherence to ART and CMDs.
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Figure 1. 
Effects of stressors and symptoms of common mental disorders on ART adherence
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Table 1
Participant Characteristics
Patients
Male 16 (34.04%)
Female 31 (65.96%)
Age Mean 41.7; SD. 11.3
SRQ Mean 5.6; SD. 1.5
CD4 Mean 306.2; SD. 187.9
1st line ART 27 (57.4%)
2nd line ART 20 (42.5%)
Healthcare Workers
Female 6 (100%)
Adherence counsellors 3 (50%)
Nurse Practitioners 2 (33.3%)
Clinical Psychologist 1 (16.7%)
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Table 2
Interview Guide
1. How are you?
2. How did you travel here today?
3. Tell me a little bit about your medication.
4. When was the last time you missed a dose?
    a. Can you tell me about what happened?
5. Describe the experience of getting drugs at the clinic for you.
6. When you were first diagnosed wit HIV and they started you on ARVs, what did they tell you?
    a. Was it useful?
7. What challenges do you face?
8. What are your reasons for staying alive?
9. I'm going to read out a list of things. (Slowly read list of symptoms of common mental disorders). Do you ever feel any of these things?
    a. Tell me about it.
10. What do you understand by “depression”?
    a. What causes it?
    b. What can be done for it?
11. We are trying to see if we can give counselling to some people who are struggling to take their medication. Has counselling been beneficial 
for you?
    a. If not, how can we help improve it?
12. What would be some of the difficulties you would face if you had to come for counselling once a week, for a month?
    a. What could make it easier to come?
13. If you wanted to talk about some of the problems you have been facing, what would be the best setting?
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